September 13-18, 2014, Maine, USA: On Gordon Research Conference Drug Resistance Session, the section’s founder Dr. M. Riley invited Dr. X. Qiu for a poster presentation, first time introduced his Pheromonicin guided drug design platform: the frontier discovery, the novel principle, the proprietary technology and methodology, the cross biosphere practices, several certified lab test proofs and completed clinical trial phases on large animal.
October 19-23, 2014, Beijing, China: On 18th Beijing International Bio-pharmaceutical Forum, Dr. M. Riley (University of Massachusett) and Dr. X. Qiu (Pheromonicin Biotech, Ltd.) were invited to gave a pair of speeches to respectively introduce bacteriocin research as continuous research directions toward replacement of conventional antibiotic treatments against drug-resistance; and how Pheromonicin guided drug design platform as solutions that has practically shortened years of journey to finally bring bacteriocin into front of a pharmaceutical revolution.